×

Onyx rejects $10 billion bid from Amgen

6:25 PM ET Mon, 1 July 2013

Onyx Pharmaceuticals is seeking out more competitive offers beyond Amgen's $10 billion takeover bid. "Mad Money" host Jim Cramer says there are better opportunities in the biotech space right now.